TELA Bio, Inc. Income Tax Expense
TELA Bio, Inc. (TELA) reported Income Tax Expense of $60.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Expense Statement › Income Tax
us-gaap:IncomeTaxExpenseBenefit · last filed 2026-08-11
- TELA Bio, Inc. income tax expense (benefit) for the quarter ending 2026-06-30 was $60.00K, a 81.82% increase year-over-year.
- TELA Bio, Inc. income tax expense (benefit) for the quarter ending 2026-03-31 was $60.00K, a 15.38% increase year-over-year.
- TELA Bio, Inc. income tax expense (benefit) for the quarter ending 2025-12-31 was $145.00K.
- TELA Bio, Inc. income tax expense (benefit) for the quarter ending 2025-09-30 was $0.00.
- TELA Bio, Inc. income tax expense (benefit) for fiscal 2025 was $230.00K.
- TELA Bio, Inc. income tax expense (benefit) for fiscal 2024 was -$144.00K.
| Period end | Income Tax Expense (Benefit) 3 month | Income Tax Expense (Benefit) 6 month | Income Tax Expense (Benefit) 9 month | Income Tax Expense (Benefit) 12 month |
|---|---|---|---|---|
| 2026-06-30 | $60.00K 10-Q · filed 2026-08-11 | $120.00K 10-Q · filed 2026-08-11 | $265.00K derived: sum of 3 quarters · filed 2026-08-11 | $265.00K derived: sum of 4 quarters · filed 2026-08-11 |
| 2026-03-31 | $60.00K 10-Q · filed 2026-05-13 | $205.00K derived: sum of 2 quarters · filed 2026-05-13 | $205.00K derived: sum of 3 quarters · filed 2026-05-13 | $238.00K derived: sum of 4 quarters · filed 2026-08-11 |
| 2025-12-31 | $145.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | $145.00K derived: sum of 2 quarters · filed 2026-03-25 | $178.00K derived: sum of 3 quarters · filed 2026-08-11 | $230.00K 10-K · filed 2026-03-25 |
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | $33.00K derived: sum of 2 quarters · filed 2026-08-11 | $85.00K 10-Q · filed 2025-11-14 | |
| 2025-06-30 | $33.00K 10-Q · filed 2026-08-11 | $85.00K 10-Q · filed 2026-08-11 | ||
| 2025-03-31 | $52.00K 10-Q · filed 2026-05-13 | |||
| 2024-12-31 | -$144.00K 10-K · filed 2026-03-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| Spectral AI, Inc. (MDAI) | United States | $0.052B | |
| Sensus Healthcare, Inc. (SRTS) | United States | $0.048B | -3.24 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 | |
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| NEPHROS INC (NEPH) | United States | $0.046B | 23.02 |
| SANUWAVE Health, Inc. (SNWV) | United States | $0.041B | 5.47 |
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |
| RenovoRx, Inc. (RNXT) | United States | $0.076B | -3.62 |
| InspireMD, Inc. (NSPR) | $0.033B |